REG - Axis Bank Ltd Axis Bank Ltd (144A) - Press Release - Acquisition of shares of Max Life

Axis BankAnnouncement

06/04/2021 14:15

RNS Number : 5426U
  
Axis Bank Limited
  
06 April 2021
  
 

AXIS/CO/CS/16/2021-22
 
6th April 2021               
 
Dear Sirs/Ma'am,
 
Sub: Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations 
and Disclosure Requirements) Regulations, 2015 
 
This is with reference to our earlier disclosure letters dated 28th April 2020, 23rd July 2020, 24thAugust 2020 and 30thOctober 2020 on execution of definitive agreements by Axis Bank Limited ("Axis Bank") with Max Financial Services Limited ("Max Financial") for acquisition of a part of the equity share capital of Max Life Insurance Company Limited ("Max Life"), a material subsidiary of  Max Financial, by Axis Bank and its subsidiaries, i.e., Axis Securities Limited and Axis Capital Limited (together with Axis Bank, "Axis Entities") and follow up disclosure letter dated 24thFebruary  2021 informing receipt of all requisite regulatory approvals including receipt of approval by Max Life from the Insurance Regulatory and Development Authority of India.
 
In this regard, we would like to inform you that the Axis Entities have collectively acquired shares of Max Life, by way of transfer of equity shares of Max Life from Max Financial. Axis Entities together hold 12.99% equity stake in Max Life as of date following the transfer of shares as aforesaid.  
 
A press release issued by the Bank in this regard is enclosed herewith.
http://www.rns-pdf.londonstockexchange.com/rns/5426U_1-2021-4-6.pdf
 
You are requested to take note of above and arrange to bring the same to the notice of all concerned.
 
Thanking you,
 
For Axis Bank Limited
 
 
 
Girish V. Koliyote
Company Secretary
 
Encl: As above
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
ACQDKABKNBKDKQK